▲ Peaking
Business
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
0sources
0articles
0velocity
22m agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (0)
Related trends
▲ Peaking
Business
American Airlines Just Got Hit With a Mixed Bag of News
▲ Peaking
Business
Why Honeywell Tech’s Earnings Beat Is Weighing on Aerospace Shares
Honeywell Technologies has raised its profit forecast following a Q2 2026 earnings beat, yet the results are impacting broader aerospace shares.
▲ Peaking
Business
Is your lettuce safe? What H-E-B, Whole Foods say as Cyclospora cases rise in Austin - Austin American-Statesman
Concerns over lettuce safety are growing as Cyclospora cases rise, prompting responses from major grocers and increased demand for local produce.
▲ Peaking
Business
Nearly 1.6M eggs recalled in Texas and nearby states over possible salmonella contamination
▲ Peaking
Business
Space Exploration Technologies Corp. (SPCX) Stock Just Lost $1 Trillion in a Month. Is the Selloff a Buying Opportunity or a Warning?
▲ Peaking
Business